Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
for
Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07187869
Phase 1, Recruiting
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
for
Amputation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06840262
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Houston TX, St Louis MO, Atlanta GA, Tampa FL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07581002
Phase 2, Phase 3, Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
for
Pulmonary Arterial Hypertension
Location: Houston TX, San Antonio TX, Dallas TX, Kansas City KS,
Sponsor: Gossamer Bio USA, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06274801
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
for
Acute Myeloid Leukemia,
Location: Houston TX, Cleveland OH, Boston MA, Portland OR
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03471260
Phase 1, Phase 2, Recruiting
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
for
Respiratory Syncytial Virus Immunization,
Location: Houston TX, Sugar Land TX, Tomball TX, Austin TX,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07734649
Phase 1, Phase 2, Recruiting
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12+
Code: NCT05360160
Phase 1, Phase 2, Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Houston TX, St Louis MO, Tampa FL, Zion IL, Goodyear AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07594106
Phase 1, Phase 2, Recruiting
A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers
for
Head and Neck Cancer
Location: Houston TX, Boston MA
Sponsor: Foundation for the National Institutes of Health
Sex: All
Age: 18+
Code: NCT01936376
Recruiting
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis
Location: Houston TX, Ann Arbor MI, Cleveland OH, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04485260
Phase 1, Phase 2, Recruiting
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
Location: Houston TX, Atlanta GA, Durham NC, Orange CA, Boston MA
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT07228442
Phase 2, Recruiting
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05111561
Phase 1, Recruiting
A Study of DM002 in Patients With Advanced Solid Tumors